It is endogenously biosynthesised in the liver and kidneys from lysine and methionine through a four-step pathway proceeding via trimethyllysine and gamma-butyrobetaine, the final hydroxylation being catalysed by gamma-butyrobetaine dioxygenase
The interaction is specifically with absorption of pills
The eligibility criteria for GLP-1 medications, also known as GLP-1 receptor agonists, typically depend on individual factors such as the severity of type 2 diabetes, overall health status, and response to other diabetes medications or lifestyle interventions
Get Started Engage with Klinic by completing an online intake form detailing your health history and insurance
Doubling frequency risks severe nausea, vomiting, diarrhea, dehydration, electrolyte imbalances, and potential pancreatitis or thyroid complications
PMC 1132909